use of a preparation containing amoxycillin and clavulanic acid for the production of a drug for the treatment of bacterial infections in paediatric patients

摘要

Paediatric aqueous liquid suspension formulations comprising amoxycillin trihydrate and potassium clavulanate in a ratio of from 6:1 to 8:1 are provided for use in a BID dosage regimen for treating bacterial infection.